Inactive Instrument
Entasis Therapeutics Holdings Inc. Share Price
Stocks
ETTX
US2936141033
Biotechnology & Medical Research
| 1 day | -0.45% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pavel Raifeld
PSD | President | 42 | 11/07/2022 |
David Altarac
CTO | Chief Tech/Sci/R&D Officer | 65 | 04/11/2019 |
Ruben Tommasi
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/05/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Heather Behanna
BRD | Director/Board Member | 51 | 01/08/2017 |
David Hastings
BRD | Director/Board Member | 64 | 01/04/2018 |
Heather Preston
BRD | Director/Board Member | 60 | 01/08/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/07/22 | Issuer sale | Chief Financial Officer | 1,53,900 | 0.3216% | ||
| 11/07/22 | Issuer sale | Executive/Senior Manager | 2,25,000 | 0.4702% | ||
| 08/07/22 | Buy | Company | 1,92,70,476 | 40.2712% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.45% | -.--% | - | - | 10Cr | ||
| -1.82% | +5.03% | +56.71% | +66.69% | 5.73TCr | ||
| -0.27% | +5.74% | +40.26% | +80.17% | 5.5TCr | ||
| -2.05% | -2.14% | +2.93% | +413.38% | 2.32TCr | ||
| +1.97% | -1.16% | -19.24% | -13.25% | 2.26TCr | ||
| -1.13% | +4.54% | +22.73% | -8.06% | 2.05TCr | ||
| +1.57% | +2.09% | +28.01% | -27.56% | 1.76TCr | ||
| -0.10% | +5.57% | +38.63% | +565.16% | 1.57TCr | ||
| +5.29% | 0.00% | +185.09% | +332.66% | 1.45TCr | ||
| +0.79% | +0.50% | +25.73% | +184.74% | 1.39TCr | ||
| Average | +0.46% | +1.62% | +42.32% | +177.10% | 2.67TCr | |
| Weighted average by Cap. | -0.06% | +1.93% | +40.37% | +137.85% |
Employees
51
















